摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(diethylamino)-1-(1-naphthalenyl)ethanone | 116855-53-9

中文名称
——
中文别名
——
英文名称
2-(diethylamino)-1-(1-naphthalenyl)ethanone
英文别名
1-<2-Diaethyl-amino-acetyl>-naphthalin;2-(diethylamino)-1-(naphthalen-1-yl)ethanone;2-(diethylamino)-1-naphthalen-1-ylethanone
2-(diethylamino)-1-(1-naphthalenyl)ethanone化学式
CAS
116855-53-9
化学式
C16H19NO
mdl
——
分子量
241.333
InChiKey
QVTCTLWNXOVOAO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    20.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-(diethylamino)-1-(1-naphthalenyl)ethanone氢氧化钾盐酸羟胺 作用下, 以 甲醇 为溶剂, 反应 17.0h, 以62%的产率得到2-(diethylamino)-1-(1-naphthalenyl)ethanone oxime
    参考文献:
    名称:
    Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents
    摘要:
    Twelve novel derivatives of the selective class III antiarrhythmic agent sematilide were prepared in an attempt to incorporate both class I and class III electrophysiological properties into a single molecule. Electrophysiological activity was determined by standard microelectrode techniques in canine cardiac Purkinje fibers. Initial assessment of class I efficacy was carried out in a ouabain-induced arrhythmia model in guinea pigs. All of the compounds prolonged action potential duration in Purkinje fibers (class III activity), and three were active against ouabain-induced arrhythmias (class I activity). Selected compounds were evaluated further in dogs for efficacy against arrhythmias occurring 24 h following coronary ligation (automatic arrhythmias) and induced by using programmed electrical stimulation techniques (reentrant arrhythmias). The most effective compounds from the series are 3g and -j, which were effective in both canine models. Molecular modeling and structure-activity relationships are discussed.
    DOI:
    10.1021/jm00164a025
  • 作为产物:
    描述:
    二乙胺2-溴-1-萘-1-乙酮 在 ice 、 silica gel 、 盐酸二氯甲烷Sodium sulfate-III乙酸乙酯 作用下, 以 甲苯 为溶剂, 反应 16.0h, 生成 2-(diethylamino)-1-(1-naphthalenyl)ethanone
    参考文献:
    名称:
    N-(aminoalkyl)-substituted(N or C
    摘要:
    该公式化合物为N-(氨基烷基)-取代(N或C烷基)-芳基-4-(甲基磺酰氨基)苯甲酰胺,其中R为C1-C4直链烷基,R1、R2和R3中的一个为苯基或萘基,另外两个为氢,--NR4R5为二级或三级氨基基团,X和X1为氢或烷基,n为0或1,可用作抗心律失常药物,特别是作为I类/III类联合药物治疗心律失常。
    公开号:
    US04920116A1
点击查看最新优质反应信息

文献信息

  • N-(aminoalkyl)-substituted(N or C
    申请人:Schering A.G.
    公开号:US04920116A1
    公开(公告)日:1990-04-24
    N-(aminoalkyl)-substituted(N or C alkyl)-aryl-4-(methylsylfonylamino)benzamides of the formula ##STR1## wherein R is C.sub.1 -C.sub.4 straight chain alkyl, one of R.sub.1, R.sub.2 and R.sub.3 is a phenyl or naphthyl group and the others are hydrogen, --NR.sub.4 R.sub.5 is a secondary or teritary amino group, X and X.sub.1 are hydrogen or alkyl and n is 0 or 1, are useful as antiarrhythmic agents in the treatment of cardiac arrhythmias especially as combination Class I/Class III agents.
    公式为##STR1##的N-(氨基烷基)-取代(N或C烷基)-芳基-4-(甲基磺酰氨基)苯甲酰胺,其中R为C.sub.1-C.sub.4直链烷基,R.sub.1、R.sub.2和R.sub.3中的一个为苯基或萘基,其余为氢,--NR.sub.4 R.sub.5为二级或三级氨基基团,X和X.sub.1为氢或烷基,n为0或1,可用于治疗心律失常,特别是作为I类/III类联合药物。
  • ARYL-N-AMINOALKYL-4-(SULFONAMIDO)BENZAMIDES, ANTIARRHYTMIC AGENTS AND COMPOSITIONS THEREOF
    申请人:SCHERING AKTIENGESELLSCHAFT
    公开号:EP0324791A1
    公开(公告)日:1989-07-26
  • US4920116A
    申请人:——
    公开号:US4920116A
    公开(公告)日:1990-04-24
  • [EN] ARYL-N-AMINOALKYL-4-(SULFONAMIDO)BENZAMIDES, ANTIARRHYTMIC AGENTS AND COMPOSITIONS THEREOF
    申请人:SCHERING AKTIENGESELLSCHAFT
    公开号:WO1988002362A1
    公开(公告)日:1988-04-07
    (EN) Novel aryl-N-aminoalkyl-4-(sulfonamido)benzamides are described as useful antiarrhytmic agents. Their use in the treatment of cardiac arrhytmias especially as combination class I/class III agents is described. Pharmaceutical formulations containing such compounds are also disclosed.(FR) Les aryl-N-aminoalkyl-4-(sulfonamido)benzamides décrites sont utiles en tant qu'agents antiarythmiques. Leur utilisation dans le traitement d'arrythmie cardiaque, spécialement comme agents de la combinaison de la classe I et de la classe III est décrite. Des compositions pharmaceutiques contenant de tels composés sont également décrites.
  • Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents
    作者:Gary B. Phillips、Thomas K. Morgan、Klaus Nickisch、Joan M. Lind、Robert P. Gomez、Ronald A. Wohl、Thomas M. Argentieri、Mark E. Sullivan
    DOI:10.1021/jm00164a025
    日期:1990.2
    Twelve novel derivatives of the selective class III antiarrhythmic agent sematilide were prepared in an attempt to incorporate both class I and class III electrophysiological properties into a single molecule. Electrophysiological activity was determined by standard microelectrode techniques in canine cardiac Purkinje fibers. Initial assessment of class I efficacy was carried out in a ouabain-induced arrhythmia model in guinea pigs. All of the compounds prolonged action potential duration in Purkinje fibers (class III activity), and three were active against ouabain-induced arrhythmias (class I activity). Selected compounds were evaluated further in dogs for efficacy against arrhythmias occurring 24 h following coronary ligation (automatic arrhythmias) and induced by using programmed electrical stimulation techniques (reentrant arrhythmias). The most effective compounds from the series are 3g and -j, which were effective in both canine models. Molecular modeling and structure-activity relationships are discussed.
查看更多